Precigen

Precigen

Yahoo Finance • 12 days ago

Precigen (PGEN) Secures FDA Orphan Drug Exclusivity for PAPZIMEOS

Precigen Inc. (NASDAQ:PGEN) is one of the penny stocks with explosive growth potential. On June 15, Precigen secured FDA orphan drug exclusivity for PAPZIMEOS, a precision medicine treating adult recurrent respiratory papillomatosis/RRP. T... Full story

Yahoo Finance • 12 days ago

Alvotech (ALVO): 10 Penny Stocks With Explosive Growth Potential

Alvotech (NASDAQ:ALVO) is one of the penny stocks with explosive growth potential. On June 18, Alvotech closed its underwritten public offering of 26,066,667 ordinary shares at $3.75 per share, raising ~$98 million in gross proceeds. This... Full story

Yahoo Finance • 19 days ago

Is Precigen (PGEN) a Stock to Sell After Its CFO Let Go of 41,000 Shares?

Key Points 41,884 shares were sold in an open-market transaction for a total of ~$183,000 on May 28, 2026. The sale reduced direct holdings by 7.0%, from 596,419 shares to 554,535 shares, with no change to indirect ownership. All shares i... Full story

Yahoo Finance • 20 days ago

Top Biotech Gainers: VRXA Begins A New Chapter, ADIL Opens Wallet, PGEN, PCSA On Watch...

(RTTNews) - Today's top gainers were led by Australia-based Gelteq, which develops a novel ingestible gel-based drug delivery platform; Adial Pharmaceuticals, which announced the acquisition of Azora Therapeutics as part of its pipeline ex... Full story

Yahoo Finance • last month

Spotlight On 3 Growth Companies With Strong Insider Stakes

The United States market has shown robust performance with a 1.2% climb in the last week and a remarkable 29% increase over the past year, alongside expectations for earnings to grow by 17% annually in the coming years. In this thriving en... Full story

Yahoo Finance • 2 months ago

Discover 3 Elite Growth Companies With Strong Insider Ownership

In the last week, the United States market has stayed flat, yet over the past 12 months, it has experienced a notable rise of 28%, with earnings forecasted to grow by 16% annually. In this environment, companies that not only demonstrate s... Full story

Yahoo Finance • 2 months ago

Is Precigen, Inc. (PGEN) A Good Stock To Buy Now?

Is PGEN a good stock to buy? We came across a bullish thesis on Precigen, Inc. on Valueinvestorsclub.com by coalone. In this article, we will summarize the bulls’ thesis on PGEN. Precigen, Inc.'s share was trading at $4.0200 as of April 28... Full story

Yahoo Finance • 2 months ago

3 Growth Companies With Insider Ownership Up To 22%

The United States market has shown positive momentum, with a 1.7% increase over the last week and a substantial 34% rise over the past year, alongside an anticipated annual earnings growth of 16%. In this thriving environment, growth compa... Full story

Yahoo Finance • 3 months ago

3 Growth Stocks With High Insider Ownership And 43% Earnings Growth

The United States market has experienced a notable upswing, climbing 4.4% in the last week and showing a robust 32% increase over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, identifying gr... Full story

Yahoo Finance • 3 months ago

Is Precigen Inc. (PGEN) The Best Healthcare Penny Stock to Buy?

Precigen Inc. (NASDAQ:PGEN) is one of the best healthcare penny stocks to buy according to hedge funds. On April 7, Precigen Inc. (NASDAQ:PGEN) reiterated its expectation that sales of its lead respiratory treatment, PAPZIMEOS, will exceed... Full story

Yahoo Finance • 3 months ago

Wall Street Bullish on ​Precigen (PGEN) As the Company Transitions to Commercial Stage

​Precigen, Inc. (NASDAQ:PGEN) is one of the Best Rising Penny Stocks to Buy Now. ​Wall Street is bullish on Precigen, Inc. (NASDAQ:PGEN) after the company posted encouraging fiscal Q4 2025 earnings on March 25. Following the release on Ap... Full story

Yahoo Finance • 3 months ago

Small-cap healthcare stocks with A+ grade EPS revisions ahead of earnings

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images As Q1 2026 earnings season approaches, the healthcare sector enters reporting season as one of the market's primary... Full story

Yahoo Finance • 3 months ago

Precigen sees Q1 revenue exceeding $18M, consensus $20.8M

“In the short time since early and full approval, the standard-of-care first-line treatment is seeing tremendous progress,” said Precigen’s (PGEN) President and CEO, Helen Sabzevari, during a conference call to discuss fourth quarter resul... Full story

Yahoo Finance • 3 months ago

Precigen expects Q1 revenue to exceed $18M as PAPZIMEOS launch accelerates with broad U.S. payer coverage

Earnings Call Insights: Precigen, Inc. (PGEN) Q4 2025 MANAGEMENT VIEW * Helen Sabzevari, President and CEO, highlighted the company's transformation to a "product revenue-generating commercial biotech company" following the full FDA ap... Full story

Yahoo Finance • 4 months ago

Precigen (PGEN) Surged Following the Early Approval of Papziemos

Patient Capital Management, a value investing firm, released its “Patient Opportunity Equity Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. In Q4 2025, Patient Opportunity Equity Strategy return... Full story

Yahoo Finance • 8 months ago

Vaxart, Precigen among biotech gainers after Q3 results

[Close up image of wooden cubes with alphabet Q3 on office desk.] mohd izzuan Shares of oral vaccine developer Vaxart (OTC:VXRT [https://seekingalpha.com/symbol/VXRT]) and immunotherapy maker Precigen (PGEN [https://seekingalpha.com/symbo... Full story

Yahoo Finance • 8 months ago

After-Hours Earnings Report for November 13, 2025 : AMAT, BAP, STN, GLOB, TMC, TRVI, PGEN, BZH, OMER, TBN, TOI, AIRJ

The following companies are expected to report earnings after hours on 11/13/2025. Visit our Earnings Calendar for a full list of expected earnings releases. Applied Materials, Inc. (AMAT)is reporting for the quarter ending October 31,... Full story

Yahoo Finance • 10 months ago

Precigen Signs a Credit Facility Agreement Worth $125 Million to Support PAPZIMEOS

Precigen, Inc. (NASDAQ:PGEN) is one of the 12 Best NASDAQ Penny Stocks to Buy According to Hedge Funds. On September 3, Precigen, Inc. (NASDAQ:PGEN) announced that it signed a credit facility agreement with total funds of up to $125 millio... Full story

Yahoo Finance • 10 months ago

Precigen announces up to $125M non-dilutive financing

* Precigen (NASDAQ:PGEN [https://seekingalpha.com/symbol/PGEN]) said on Wednesday that it has entered into a credit facility agreement [https://seekingalpha.com/pr/20218815-precigen-announces-up-to-125-million-non-dilutive-financing] wit... Full story

Yahoo Finance • 10 months ago

Citizens JMP Raises PT on Precigen from $6 to $8, Keeps Outperform Rating

Precigen Inc. (NASDAQ:PGEN) is one of the 11 Low Price High Volume Stocks to Buy According to Analysts. On August 18, Citizens JMP raised the price target on Precigen Inc. (NASDAQ:PGEN) from $6 to $8, keeping its Outperform rating on the s... Full story